Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Hitgen Inc. is managing 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 4 distinct examiners and 3 distinct art units. There are 3 distinct art units involved in these cases.
WELLS, LAUREN QUINLAN is the busiest examiner, responsible for 1 pending office action. Each of the distinct examiners handles 1 action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §112 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WELLS, LAUREN QUINLAN | 1 | 49.4% | +59.7% |
| CHAO, ALLEN | 1 | 60.0% | +0.0% |
| OLSON, ALEXANDRA NADINE | 1 | 100.0% | +0.0% |
| BAILEY, STEVEN WILLIAM | 1 | 31.6% | +15.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19027734 | SPIRO COMPOUND AND APPLICATION THEREOF | WELLS, LAUREN QUINLAN | — |
| 18324265 | DNA-ENCODED COMPOUND LIBRARY AND SCREENING METHOD THEREOF | OLSON, ALEXANDRA NADINE | — |
| 17992778 | METHOD AND APPARATUS FOR PROCESSING MOLECULAR SCAFFOLD TRANSITION, MEDIUM, ELECTRONIC DEVICE, AND COMPUTER PROGRAM PRODUCT | BAILEY, STEVEN WILLIAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19027734 | SPIRO COMPOUND AND APPLICATION THEREOF | WELLS, LAUREN QUINLAN | — |
| 17992778 | METHOD AND APPARATUS FOR PROCESSING MOLECULAR SCAFFOLD TRANSITION, MEDIUM, ELECTRONIC DEVICE, AND COMPUTER PROGRAM PRODUCT | BAILEY, STEVEN WILLIAM | — |
| Art Unit | Apps |
|---|---|
| 1622 | 2 |
| 1684 | 1 |
| 3682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19027734 | SPIRO COMPOUND AND APPLICATION THEREOF | WELLS, LAUREN QUINLAN | 1622 | §102§112 | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18725158 | MENIN INHIBITOR AND USE THEREOF | CHAO, ALLEN | 1622 | §112 | Non-Final OA | — | Pending | Jun 28, 2024 |
| 18324265 | DNA-ENCODED COMPOUND LIBRARY AND SCREENING METHOD THEREOF | OLSON, ALEXANDRA NADINE | 1684 | §102§103 | Final Rejection | — | Pending | May 26, 2023 |
| 17992778 | METHOD AND APPARATUS FOR PROCESSING MOLECULAR SCAFFOLD TRANSITION, MEDIUM, ELECTRONIC DEVICE, AND COMPUTER PROGRAM PRODUCT | BAILEY, STEVEN WILLIAM | 3682 | §101§103 | Non-Final OA | — | Pending | Nov 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHitgen Inc. has 4 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Lauren Quinlan Wells has the most, with 1 of Hitgen Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
